Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyrimidines >  Bromopyrimidine >  6-BROMO-4-CHLORO-7H-PYRROLO[2,3-D]PYRIMIDINE

6-BROMO-4-CHLORO-7H-PYRROLO[2,3-D]PYRIMIDINE

Basic information Safety Supplier Related

6-BROMO-4-CHLORO-7H-PYRROLO[2,3-D]PYRIMIDINE Basic information

Product Name:
6-BROMO-4-CHLORO-7H-PYRROLO[2,3-D]PYRIMIDINE
Synonyms:
  • 6-BROMO-4-CHLORO-7H-PYRROLO[2,3-D]PYRIMIDINE
  • 6-BroMo-4-chloro-7H-pyrro...
  • 7H-Pyrrolo[2,3-d]pyrimidine, 6-bromo-4-chloro-
  • 6-BROMO-4-CHLORO-7H-PYRROLO[2,3-D]PYRIMIDINE ISO 9001:2015 REACH
  • 6-Bromo-4-chloro-1H-pyrrolo[2,3-d]pyrimidine
CAS:
784150-41-0
MF:
C6H3BrClN3
MW:
232.47
Product Categories:
  • CHIRAL CHEMICALS
Mol File:
784150-41-0.mol
More
Less

6-BROMO-4-CHLORO-7H-PYRROLO[2,3-D]PYRIMIDINE Chemical Properties

Density 
1.996±0.06 g/cm3(Predicted)
storage temp. 
under inert gas (nitrogen or Argon) at 2–8 °C
pka
9.52±0.50(Predicted)
form 
solid
color 
Light yellow
More
Less

Safety Information

HazardClass 
IRRITANT
HS Code 
2933599590
More
Less

6-BROMO-4-CHLORO-7H-PYRROLO[2,3-D]PYRIMIDINE Usage And Synthesis

Synthesis

784150-40-9

784150-41-0

Synthesis of compound 20.2. Potassium tert-butanolate (1.2 g, 10 mmol) was added to a solution of tetrahydrofuran (THF, 24 mL) of compound 20.1 (6-bromo-4-chloro-7-(phenylsulfonyl)-7H-pyrrolo[2,3-D]pyrimidine, 800 mg, 2.2 mmol). The reaction mixture was stirred at room temperature for 16 hours. Upon completion of the reaction, the reaction was quenched by the addition of saturated sodium bicarbonate (NaHCO3) solution. The reaction mixture was extracted with ethyl acetate (EtOAc, 3 × 100 mL). The organic layers were combined, washed sequentially with water and brine, and then dried over anhydrous sodium sulfate (Na2SO4). The solvent was evaporated under reduced pressure to give the crude product. The crude product was purified by fast column chromatography using silica gel (SiO2) as stationary phase and hexane/ethyl acetate (100/0 to 0/100) as eluent to afford compound 20.2 (6-bromo-4-chloro-7H-pyrrolo[2,3-d]pyrimidine, 400 mg, 80% yield). The product was characterized by 1H-NMR (200 MHz, DMSO-d6) and mass spectrometry (MS): 1H-NMR δ 13.41 (broad single peak, 1H), 8.57 (single peak, 1H), 6.79 (single peak, 1H); MS m/z 232 [M + 1]+.

References

[1] Patent: US2009/5359, 2009, A1. Location in patent: Page/Page column 27
[2] Journal of Medicinal Chemistry, 2015, vol. 58, # 18, p. 7431 - 7448
[3] Tetrahedron Letters, 2010, vol. 51, # 27, p. 3597 - 3598

6-BROMO-4-CHLORO-7H-PYRROLO[2,3-D]PYRIMIDINESupplier

3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Email
3bsc@sina.com
Capot Chemical Co., Ltd
Tel
+86 (0) 571 85 58 67 18
Nanjing Chemlin Chemical Co., Ltd
Tel
025-83697070
Email
info@chemlin.com.cn
SpringPharma Tech Co.,Ltd
Tel
+86-25-68710855, +86-25-68710897
Email
sales@springpharma.net
Hangzhou Yuhao Chemical Technology Co., Ltd
Tel
0571-82693216
Email
info@yuhaochemical.com
More
Less

6-BROMO-4-CHLORO-7H-PYRROLO[2,3-D]PYRIMIDINE(784150-41-0)Related Product Information